Table 2. ORs of Outcomes in NLR Groups on Day 1 and Day 7 of Treatment.
| Outcomes | Day 1 |
Day 7 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| N | NLR < 10 | NLR > 11 | Unadjusted odds (P value) | aOR (P value) | N | NLR < 10 | NLR > 11 | Unadjusted odds (P value) | aOR (P value) | |
| Vent | 57 | 46 (81%) | 11 (19%) | OR 1.5 (0.6 - 3.5, P = 0.46) | aOR 1.5 (0.6 - 3.7, P = 0.33) | 55 | 36 (66%) | 19 (34%) | OR 3.3 (1.4 - 7.7, P = 0.008) | aOR 3.1 (1.2 - 8.4, P = 0.024) |
| No vent | 110 | 95 (86%) | 15 (14%) | 80 | 69 (86%) | 11 (14%) | ||||
| Upgrade | 53 | 42 (79%) | 11 (21%) | OR 1.7 (0.7 - 4.1, P = 0.30) | aOR 1.7 (0.7 - 4.1, P = 0.24) | 50 | 34 (68%) | 16 (32%) | OR 2.4 (1.0 - 5.4, P = 0.06) | aOR 2.3 (0.9 - 6.1, P = 0.08) |
| No upgrade | 114 | 99 (87%) | 15 (13%) | 85 | 71 (84%) | 14 (16%) | ||||
| Dialysis | 10 | 7 (70%) | 3 (30%) | OR 2.5 (0.6 - 10.3, P = 0.39) | aOR 2.5 (0.5 - 11.2, P = 0.25) | 8 | 6 (75%) | 2 (25%) | OR 1.2 (0.2 - 6.1, P = 0.81) | aOR 0.7 (0.1 - 5.7, P = 0.73) |
| No dialysis | 157 | 134 (85%) | 23 (15%) | 127 | 99 (78%) | 28 (22%) | ||||
| Died | 18 | 14 (78%) | 4 (22%) | OR 1.6 (0.5 - 5.5, P = 0.63) | aOR 1.9 (0.5 - 6.7, P = 0.30) | 18 | 12 (67%) | 6 (33%) | OR 11.0 (3.6 - 33.0, P < 0.0001) | aOR 11.1 (3.11 - 39.1, P < 0.0001) |
| Alive | 149 | 127 (85%) | 22 (15%) | 117 | 99 (85%) | 18 (15%) | ||||
aOR: adjusted odds ratio; OR: odds ratio; NLR: neutrophil-to-lymphocyte ratio.